← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 4, 2020Last known activity
Oct 2, 2020
Timeline
No events for the selected filters.
Drugs by trial phase (2 distinct, 2 trials)
Phase 3 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (6)
- NCT04682964Reponsible party - principal investigatorPhase 3Oct 2, 2020
- NCT04682964Study directorPhase 3Oct 2, 2020
- NCT04682964Lead sponsorPhase 3Oct 2, 2020
- NCT04702542Reponsible party - principal investigatorN/AJan 4, 2020
- NCT04702542Study directorN/AJan 4, 2020
- NCT04702542Lead sponsorN/AJan 4, 2020
Details
- Last known activity
- Oct 2, 2020